Protecting the melatonin rhythm through circadian healthy light exposure

International Journal of Molecular Sciences

Volumn 15, Issue 12, 2014, Pages 23448-23500

  Bonmati Carrion, Maria Angeles ^a   Arguelles Prieto, Raquel ^a   Martinez Madrid, Maria Jose ^a   Reiter, Russel ^b   Hardeland, Ruediger ^c   Rol, Maria Angeles ^a   Madrid, Juan Antonio ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b University of Texas Health Science Center   (United States)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Chronodisruption; Circadian; Light at night (LAN); Melanopsin; Melatonin

Indexed keywords

MELANOPSIN; MELATONIN;

AGING; BLINDNESS; BLUE LIGHT; CIRCADIAN RHYTHM; GENE EXPRESSION; HUMAN; ILLUMINATION; JET LAG; LIGHT DARK CYCLE; LIGHT EXPOSURE; LIGHT INTENSITY; NONHUMAN; PHOTORECEPTOR; RETINA GANGLION CELL; REVIEW; SEASONAL AFFECTIVE DISORDER; SHIFT WORKER; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS; ANIMAL; HEALTH; LIGHT; PHOTOPERIODICITY; PHYSIOLOGY; RETINA;

ANIMALS; CIRCADIAN RHYTHM; HEALTH; HUMANS; LIGHT; LIGHTING; MELATONIN; PHOTOPERIOD; RETINA;

EID: 84919340797     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151223448     Document Type: Review

References (398)

1. Haim, A.; Portnov, B.A. Light Pollution as a New Risk Factor for Human Breast and Prostate Cancers; Springer Netherlands: Dordrecht, The Netherlands, 2013.
2. De Beaune, S.A.; White, R. Ice Age Lamps. Sci. Am. 1993, 206, 108-113.
3. Nordhaus, W.D.; Nordhaus, W.D. Do real-output and real-wage measures capture reality? The history of lighting suggests not. In The Economics of New Goods; Brenahan, T.F., Gordon, J., Eds.; The University of Chicago Press: Chicago, IL, USA, 1994; pp. 27-70.
4. Cinzano, P.; Falchi, F.; Elvidge, C.D. The first world atlas of the artificial night sky brightness. Mon. Not. R. Astron. Soc. 2001, 328, 689-707.
5. Navara, K.J.; Nelson, R.J. The dark side of light at night: Physiological, epidemiological, and ecological consequences. J. Pineal Res. 2007, 43, 215-224.
6. Pauley, S.M. Lighting for the human circadian clock: Recent research indicates that lighting has become a public health issue. Med. Hypothes. 2004, 63, 588-596.
7. Mills, P.R.; Tomkins, S.C.; Schlangen, L.J.M. The effect of high correlated colour temperature office lighting on employee wellbeing and work performance. J. Circadian Rhythm. 2007, 5, 2.
8. Erren, T.C.; Reiter, R.J. Light Hygiene: Time to make preventive use of insights-old and new- into the nexus of the drug light, melatonin, clocks, chronodisruption and public health. Med. Hypothes. 2009, 73, 537-541.
9. Roenneberg, T.; Daan, S.; Merrow, M. The art of entrainment. J. Biol. Rhythm. 2003, 18, 183-194.
10. Schmidt, C.; Collette, F.; Cajochen, C.; Peigneux, P. A time to think: Circadian rhythms in human cognition. Cogn. Neuropsychol. 2007, 24, 755-789.
11. Garaulet, M.; Madrid, J.A. Chronobiological aspects of nutrition, metabolic syndrome and obesity. Adv. Drug Deliv. Rev. 2010, 62, 967-978.
12. Green, C.B.; Takahashi, J.S.; Bass, J. The meter of metabolism. Cell 2008, 134, 728-742.
13. Moore, R.Y.; Eichler, V.B. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res. 1972, 42, 201-206.
14. Stratmann, M.; Schibler, U. Properties, entrainment, and physiological functions of mammalian peripheral oscillators. J. Biol. Rhythm. 2006, 21, 494-506.
15. Ko, C.H.; Takahashi, J.S. Molecular components of the mammalian circadian clock. Hum. Mol. Genet. 2006, 15, R271-R277.
16. Buhr, E.D.; Takahashi, J.S. Molecular components of the Mammalian circadian clock. Handb. Exp. Pharmacol. 2013, 217, 3-27.
17. Goriki, A.; Hatanaka, F.; Myung, J.; Kim, J.K.; Yoritaka, T.; Tanoue, S.; Abe, T.; Kiyonari, H.; Fujimoto, K.; Kato, Y.; et al. A novel protein, CHRONO, functions as a core component of the mammalian circadian clock. PLoS Biol. 2014, 12, e1001839.
18. Hardeland, R.; Madrid, J.A.; Tan, D.-X.; Reiter, R.J. Melatonin, the circadian multioscillator system and health: The need for detailed analyses of peripheral melatonin signaling. J. Pineal Res. 2012, 52, 139-166.
19. Ramsey, K.M.; Yoshino, J.; Brace, C.S.; Abrassart, D.; Kobayashi, Y.; Marcheva, B.; Hong, H.-K.; Chong, J.L.; Buhr, E.D.; Lee, C.; et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 2009, 324, 651-654.
20. Eckel-Mahan, K.L.; Patel, V.R.; de Mateo, S.; Orozco-Solis, R.; Ceglia, N.J.; Sahar, S.; Dilag-Penilla, S.A.; Dyar, K.A.; Baldi, P.; Sassone-Corsi, P. Reprogramming of the circadian clock by nutritional challenge. Cell 2013, 155, 1464-1478.
21. Chen, L.; Yang, G. PPARs Integrate the mammalian clock and energy metabolism. PPAR Res. 2014, 2014, 653017.
22. Nakahata, Y.; Kaluzova, M.; Grimaldi, B.; Sahar, S.; Hirayama, J.; Chen, D.; Guarente, L.P.; Sassone-Corsi, P. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008, 134, 329-340.
23. Grimaldi, B.; Nakahata, Y.; Kaluzova, M.; Masubuchi, S.; Sassone-Corsi, P. Chromatin remodeling, metabolism and circadian clocks: The interplay of CLOCK and SIRT1. Int. J. Biochem. Cell Biol. 2009, 41, 81-86.
24. Lee, Y.; Kim, E.-K. AMP-activated protein kinase as a key molecular link between metabolism and clockwork. Exp. Mol. Med. 2013, 45, e33.
25. Robles, M.S.; Boyault, C.; Knutti, D.; Padmanabhan, K.; Weitz, C.J. Identification of RACK1 and protein kinase Calpha as integral components of the mammalian circadian clock. Science 2010, 327, 463-466.
26. Nam, H.J.; Boo, K.; Kim, D.; Han, D.-H.; Choe, H.K.; Kim, C.R.; Sun, W.; Kim, H.; Kim, K.; Lee, H.; et al. Phosphorylation of LSD1 by PKCα is crucial for circadian rhythmicity and phase resetting. Mol. Cell 2014, 53, 791-805.
27. Hardeland, R. Melatonin and circadian oscillators in aging-A dynamic approach to the multiply connected players. Interdisc. Top. Gerontol. 2014, 40, 128-140.
28. Hardeland, R. Melatonin and the theories of aging: A critical appraisal of melatonin’s role in antiaging mechanisms. J. Pineal Res. 2013, 55, 325-356.
29. Yang, X.; Wood, P.A.; Ansell, C.M.; Quiton, D.F.T.; Oh, E.-Y.; Du-Quiton, J.; Hrushesky, W.J.M. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol. Int. 2009, 26, 1323-1339.
30. Fu, L.; Pelicano, H.; Liu, J.; Huang, P.; Lee, C.C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002, 111, 41-50.
31. Wood, P.A.; Yang, X.; Taber, A.; Oh, E.-Y.; Ansell, C.; Ayers, S.E.; Al-Assaad, Z.; Carnevale, K.; Berger, F.G.; Peña, M.M.O.; et al. Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol. Cancer Res. 2008, 6, 1786-1793.
32. Yang, X.; Wood, P.A.; Oh, E.-Y.; Du-Quiton, J.; Ansell, C.M.; Hrushesky, W.J.M. Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res. Treat. 2009, 117, 423-431.
33. Mullenders, J.; Fabius, A.W.M.; Madiredjo, M.; Bernards, R.; Beijersbergen, R.L. A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway. PLoS One 2009, 4, e4798.
34. Jung, C.-H.; Kim, E.M.; Park, J.K.; Hwang, S.-G.; Moon, S.-K.; Kim, W.-J.; Um, H.-D. Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway. Oncol. Rep. 2013, 29, 2109-2113.
35. Chini, C.C.S.; Escande, C.; Nin, V.; Chini, E.N. DBC1 (Deleted in Breast Cancer 1) modulates the stability and function of the nuclear receptor Rev-erbα. Biochem. J. 2013, 451, 453-461.
36. Berson, D.M.; Dunn, F.A.; Takao, M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002, 295, 1070-1073.
37. Dacey, D.M.; Liao, H.-W.; Peterson, B.B.; Robinson, F.R.; Smith, V.C.; Pokorny, J.; Yau, K.-W.; Gamlin, P.D. Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature 2005, 433, 749-754.
38. Jusuf, P.R.; Lee, S.C.S.; Hannibal, J.; Grünert, U. Characterization and synaptic connectivity of melanopsin-containing ganglion cells in the primate retina. Eur. J. Neurosci. 2007, 26, 2906-2921.
39. Van Someren, E.J.W.; Riemersma-van Der Lek, R.F. Live to the rhythm, slave to the rhythm. Sleep Med. Rev. 2007, 11, 465-484.
40. Zhou, Q.-Y.; Cheng, M.Y. Prokineticin 2 and circadian clock output. FEBS J. 2005, 272, 5703-5709.
41. Buijs, R.M.; la Fleur, S.E.; Wortel, J.; van Heyningen, C.; Zuiddam, L.; Mettenleiter, T.C.; Kalsbeek, A.; Nagai, K.; Niijima, A. The suprachiasmatic nucleus balances sympathetic and parasympathetic output to peripheral organs through separate preautonomic neurons. J. Comp. Neurol. 2003, 464, 36-48.
42. Moore, R.Y. Neural control of the pineal gland. Behav. Brain Res. 1996, 73, 125-130.
43. Hardeland, R.; Poeggeler, B.; Balzer, I.; Behrmann, G. A hypothesis on the evolutionary origins of photoperiodism based on circadian rhythmicity of melatonin in phylogenetically distant organisms. In Chronobiology & Chronomedicine; Gutenbrunner, C., Hildebrandt, G., Moog, R., Eds.; Lang: Frankfurt, Germany, 1993; pp. 113-120.
44. La Fleur, S.E.; Kalsbeek, A.; Wortel, J.; Buijs, R.M. Polysynaptic neural pathways between the hypothalamus, including the suprachiasmatic nucleus, and the liver. Brain Res. 2000, 871, 50-56.
45. Buijs, R.M.; Chun, S.J.; Niijima, A.; Romijn, H.J.; Nagai, K. Parasympathetic and sympathetic control of the pancreas: A role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake. J. Comp. Neurol. 2001, 431, 405-423.
46. Kalsbeek, A.; Fliers, E.; Franke, A.N.; Wortel, J.; Buijs, R.M. Functional connections between the suprachiasmatic nucleus and the thyroid gland as revealed by lesioning and viral tracing techniques in the rat. Endocrinology 2000, 141, 3832-3841.
47. Espiritu, R.C.; Kripke, D.F.; Ancoli-Israel, S.; Mowen, M.A.; Mason, W.J.; Fell, R.L.; Klauber, M.R.; Kaplan, O.J. Low illumination experienced by San Diego adults: Association with atypical depressive symptoms. Biol. Psychiatry 1994, 35, 403-407.
48. Hébert, M.; Dumont, M.; Paquet, J. Seasonal and diurnal patterns of human illumination under natural conditions. Chronobiol. Int. 1998, 15, 59-70.
49. Mishima, K.; Okawa, M.; Shimizu, T.; Hishikawa, Y. Diminished melatonin secretion in the elderly caused by insufficient environmental illumination. J. Clin. Endocrinol. Metab. 2001, 86, 129-134.
50. Savides, T.J.; Messin, S.; Senger, C.; Kripke, D.F. Natural light exposure of young adults. Physiol. Behav. 1986, 38, 571-574.
51. Martinez-Nicolas, A.; Ortiz-Tudela, E.; Madrid, J.A.; Rol, M.A. Crosstalk between environmental light and internal time in humans. Chronobiol. Int. 2011, 28, 617-629.
52. Francis, G.; Bishop, L.; Luke, C.; Middleton, B.; Williams, P.; Arendt, J. Sleep during the Antarctic winter: Preliminary observations on changing the spectral composition of artificial light. J. Sleep Res. 2008, 17, 354-360.
53. Mottram, A.R.; Svenson, J.E. Rhythm disturbances. Emerg. Med. Clin. N. Am. 2011, 29, 729-746.
54. Reiter, R.J.; Tan, D.-X.; Korkmaz, A.; Erren, T.C.; Piekarski, C.; Tamura, H.; Manchester, L.C. Light at night, chronodisruption, melatonin suppression, and cancer risk: A review. Crit. Rev. Oncog. 2007, 13, 303-328.
55. Arendt, J. Biological rhythms during residence in polar regions. Chronobiol. Int. 2012, 29, 379-394.
56. Stokkan, K.A.; Reiter, R.J. Melatonin rhythms in Arctic urban residents. J. Pineal Res. 1994, 16, 33-36.
57. Erren, T.C.; Piekarski, C. Does winter darkness in the Artic protect against cancer? The melatonin hypothesis revisited. Med. Hypothes. 1999, 53, 1-5.
58. Sainz, R.M.; Mayo, J.C.; Rodriguez, C.; Tan, D.X.; Lopez-Burillo, S.; Reiter, R.J. Melatonin and cell death: Differential actions on apoptosis in normal and cancer cells. Cell Mol. Life Sci. 2003, 60, 1407-1426.
59. Leon-Blanco, M.M.; Guerrero, J.M.; Reiter, R.J.; Calvo, J.R.; Pozo, D. Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J. Pineal Res. 2003, 35, 204-211.
60. Di Bella, G.; Mascia, F.; Gualano, L.; di Bella, L. Melatonin anticancer effects: Review. Int. J. Mol. Sci. 2013, 14, 2410-2430.
61. Jaworek, J.; Leja-Szpak, A. Melatonin influences pancreatic cancerogenesis. Histol. Histopathol. 2014, 29, 423-431.
62. Cutando, A.; López-Valverde, A.; de Vicente, J.; Gimenez, J.L.; Carcía, I.A.; de Diego, R.G. Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (Review). Oncol. Lett. 2014, 7, 923-926.
63. Rosenthal, N.E.; Sack, D.A.; Gillin, J.C.; Lewy, A.J.; Goodwin, F.K.; Davenport, Y.; Mueller, P.S.; Newsome, D.A.; Wehr, T.A. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch. Gen. Psychiatry 1984, 41, 72-80.
64. Straif, K.; Baan, R.; Grosse, Y.; Secretan, B.; el Ghissassi, F.; Bouvard, V.; Altieri, A.; Benbrahim-Tallaa, L.; Cogliano, V. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007, 8, 1065-1066.
65. Kelleher, F.C.; Rao, A.; Maguire, A. Circadian molecular clocks and cancer. Cancer Lett. 2014, 342, 9-18.
66. Dumont, M.; Paquet, J. Progressive decrease of melatonin production over consecutive days of simulated night work. Chronobiol. Int. 2014, 15, 1-8.
67. Erren, T.C.; Reiter, R.J. Defining chronodisruption. J. Pineal Res. 2009, 46, 245-247.
68. Davis, S.; Mirick, D.K.; Stevens, R.G. Night shift work, light at night, and risk of breast cancer. J. Natl. Cancer Inst. 2001, 93, 1557-1562.
69. Schernhammer, E.S.; Laden, F.; Speizer, F.E.; Willett, W.C.; Hunter, D.J.; Kawachi, I.; Colditz, G. a Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J. Natl. Cancer Inst. 2001, 93, 1563-1568.
70. Schernhammer, E.S.; Kroenke, C.H.; Laden, F.; Hankinson, S.E. Night work and risk of breast cancer. Epidemiology 2006, 17, 108-111.
71. Erren, T.C.; Reiter, R.J. A generalized theory of carcinogenesis due to chronodisruption. Neuro Endocrinol. Lett. 2008, 29, 815-21.
72. Schernhammer, E.S.; Speizer, F.E.; Walter, C.; Hunter, D.J.; Fuchs, C.S.; Colditz, G.A. Night-shift work and risk of colorectal cancer in the nurses’ health study. J. Natl. Cancer Inst. Cancer Inst. 2003, 95, 825-828.
73. Viswanathan, A.N.; Hankinson, S.E.; Schernhammer, E.S. Night shift work and the risk of endometrial cancer. Cancer Res. 2007, 67, 10618-10622.
74. Ben-Shlomo, R. Chronodisruption, cell cycle checkpoints and DNA repair. Indian J. Exp. Biol. 2014, 52, 399-403.
75. Ben-Shlomo, R.; Kyriacou, C.P. Light pulses administered during the circadian dark phase alter expression of cell cycle associated transcripts in mouse brain. Cancer Genet. Cytogenet. 2010, 197, 65-70.
76. Escribano, B.M.; Moreno, A.; Tasset, I.; Túnez, I. Impact of light/dark cycle patterns on oxidative stress in an adriamycin-induced nephropathy model in rats. PLoS One 2014, 9, e97713.
77. Megdal, S.P.; Kroenke, C.H.; Laden, F.; Pukkala, E.; Schernhammer, E.S. Night work and breast cancer risk: A systematic review and meta-analysis. Eur. J. Cancer 2005, 41, 2023-2032.
78. Stevens, R.G. Electric power use and breast cancer: A hypothesis. Am. J. Epidemiol. 1987, 125, 556-561.
79. Stokkan, K.A.; Yamazaki, S.; Tei, H.; Sakaki, Y.; Menaker, M. Entrainment of the circadian clock in the liver by feeding. Science 2001, 291, 490-493.
80. Mistlberger, R.E.; Yamazaki, S.; Pendergast, J.S.; Landry, G.J.; Takumi, T.; Nakamura, W. Comment on “Differential rescue of light- and food-entrainable circadian rhythms”. Science 2008, 322, 675.
81. De Martino, M.M.F.; Abreu, A.C.B.; Barbosa, M.F. dos S.; Teixeira, J.E.M. The relationship between shift work and sleep patterns in nurses. Cien. Saude Colet. 2013, 18, 763-768.
82. Aasm International Classification of Sleep Disorders: Diagnostic and Coding Manual. (ICSD-2); Thorpy, M.J., Ed.; American Academy of Sleep Medicine (Publisher): Westchester, NY, USA, 2005.
83. Winget, C.M.; DeRoshia, C.W.; Markley, C.L.; Holley, D.C. A review of human physiological and performance changes associated with desynchronosis of biological rhythms. Aviat. Space Environ. Med. 1984, 55, 1085-1096.
84. Waterhouse, J.; Reilly, T.; Atkinson, G.; Edwards, B. Jet lag: Trends and coping strategies. Lancet 2007, 369, 1117-1129.
85. Brown, G.M.; Pandi-Perumal, S.R.; Trakht, I.; Cardinali, D.P. Melatonin and its relevance to jet lag. Travel Med. Infect. Dis. 2009, 7, 69-81.
86. Wittmann, M.; Dinich, J.; Merrow, M.; Roenneberg, T. Social jetlag: Misalignment of biological and social time. Chronobiol. Int. 2006, 23, 497-509.
87. Cajochen, C.; Frey, S.; Anders, D.; Späti, J.; Bues, M.; Pross, A.; Mager, R.; Wirz-Justice, A.; Stefani, O. Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance. J. Appl. Physiol. 2011, 110, 1432-1438.
88. Wood, B.; Rea, M.S.; Plitnick, B.; Figueiro, M.G. Light level and duration of exposure determine the impact of self-luminous tablets on melatonin suppression. Appl. Ergon. 2013, 44, 237-240.
89. Lanaj, K.; Johnson, R.E.; Barnes, C.M. Beginning the workday yet already depleted? Consequences of late-night smartphone use and sleep. Organ. Behav. Hum. Decis. Process. 2014, 124, 11-23.
90. Matricciani, L.; Olds, T.; Petkov, J. In search of lost sleep: Secular trends in the sleep time of school-aged children and adolescents. Sleep Med. Rev. 2012, 16, 203-211.
91. Kohyama, J. A newly proposed disease condition produced by light exposure during night: Asynchronization. Brain Dev. 2009, 31, 255-273.
92. Liu, X.; Zhao, Z.; Jia, C.; Buysse, D.J. Sleep patterns and problems among chinese adolescents. Pediatrics 2008, 121, 1165-1173.
93. Roberts, R.E.; Roberts, C.R.; Chan, W. Persistence and change in symptoms of insomnia among adolescents. Sleep 2008, 31, 177-184.
94. García-Jiménez, M.A.; Salcedo-Aguilar, F.; Rodríguez-Almonacid, F.M.; Redondo-Martínez, M.P.; Monterde-Aznar, M.L.; Marcos-Navarro, A.I.; Torrijos-Martínez, M.P. The prevalence of sleep disorders among adolescents in Cuenca, Spain. Rev. Neurol. 2004, 39, 18-24.
95. Calamaro, C.J.; Mason, T.B.A.; Ratcliffe, S.J. Adolescents living the 24/7 lifestyle: Effects of caffeine and technology on sleep duration and daytime functioning. Pediatrics 2009, 123, e1005-e1010.
96. Eastman, C.I.; Gazda, C.J.; Burgess, H.J.; Crowley, S.J.; Fogg, L.F. Advancing circadian rhythms before eastward flight: A strategy to prevent or reduce jet lag. Sleep 2005, 28, 33-44.
97. Houpt, T.A.; Boulos, Z.; Moore-Ede, M.C. MidnightSun: Software for determining light exposure and phase-shifting schedules during global travel. Physiol. Behav. 1996, 59, 561-568.
98. Revell, V.L.; Eastman, C.I. How to trick mother nature into letting you fly around or stay up all night. J. Biol. Rhythm. 2005, 20, 353-365.
99. Cardinali, D.P.; Bortman, G.P.; Liotta, G.; Pérez Lloret, S.; Albornoz, L.E.; Cutrera, R.A.; Batista, J.; Ortega Gallo, P. A multifactorial approach employing melatonin to accelerate resynchronization of sleep-wake cycle after a 12 time-zone westerly transmeridian flight in elite soccer athletes. J. Pineal Res. 2002, 32, 41-46.
100. Claustrat, B.; Brun, J.; David, M.; Sassolas, G.; Chazot, G. Melatonin and jet lag: Confirmatory result using a simplified protocol. Biol. Psychiatry 1992, 32, 705-711.
101. Arendt, J.; Skene, D.J.; Middleton, B.; Lockley, S.W.; Deacon, S. Efficacy of melatonin treatment in jet lag, shift work, and blindness. J. Biol. Rhythm. 1997, 12, 604-617.
102. Chen, S.-K.; Badea, T.C.; Hattar, S. Photoentrainment and pupillary light reflex are mediated by distinct populations of ipRGCs. Nature 2011, 476, 92-95.
103. Petrie, K.; Dawson, A.G.; Thompson, L.; Brook, R. A double-blind trial of melatonin as a treatment for jet lag in international cabin crew. Biol. Psychiatry 1993, 33, 526-530.
104. Herxheimer, A.; Petrie, K.J. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst. Rev. 2002, doi:10.1002/14651858.CD001520.
105. Vinzio, S.; Ruellan, A.; Perrin, A.-E.; Schlienger, J.-L.; Goichot, B. Actigraphic assessment of the circadian rest-activity rhythm in elderly patients hospitalized in an acute care unit. Psychiatry Clin. Neurosci. 2003, 57, 53-58.
106. Missildine, K.; Bergstrom, N.; Meininger, J.; Richards, K.; Foreman, M.D. Sleep in hospitalized elders: A pilot study. Geriatr. Nurs. 2010, 31, 263-271.
107. Boyko, Y.; Ording, H.; Jennum, P. Sleep disturbances in critically ill patients in ICU: How much do we know? Acta Anaesthesiol. Scand. 2012, 56, 950-958.
108. Figueroa-Ramos, M.I.; Arroyo-Novoa, C.M.; Lee, K.A.; Padilla, G.; Puntillo, K.A. Sleep and delirium in ICU patients: A review of mechanisms and manifestations. Intensiv. Care Med. 2009, 35, 781-795.
109. Perras, B.; Meier, M.; Dodt, C. Light and darkness fail to regulate melatonin release in critically ill humans. Intensiv. Care Med. 2007, 33, 1954-1958.
110. Erren, T.C.; Reiter, R.J. Revisiting chronodisruption: When the physiological nexus between internal and external times splits in humans. Naturwissenschaften 2013, 100, 291-298.
111. Ortiz-Tudela, E.; Martinez-Nicolas, A.; Campos, M.; Rol, M.Á.; Madrid, J.A. A new integrated variable based on thermometry, actimetry and body position (TAP) to evaluate circadian system status in humans. PLoS Comput. Biol. 2010, 6, e1000996.
112. Ortiz-Tudela, E.; Iurisci, I.; Beau, J.; Karaboue, A.; Moreau, T.; Rol, M.A.; Madrid, J.A.; Lévi, F.; Innominato, P.F. The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy. Int. J. Cancer 2014, 134, 2717-2225.
113. Zornoza-Moreno, M.; Fuentes-Hernández, S.; Sánchez-Solis, M.; Rol, M.Á.; Larqué, E.; Madrid, J.A. Assessment of circadian rhythms of both skin temperature and motor activity in infants during the first 6 months of life. Chronobiol. Int. 2011, 28, 330-337.
114. Corbalán-Tutau, M.D.; Madrid, J.A.; Ordovás, J.M.; Smith, C.E.; Nicolás, F.; Garaulet, M. Differences in daily rhythms of wrist temperature between obese and normal-weight women: Associations with metabolic syndrome features. Chronobiol. Int. 2011, 28, 425-433.
115. Erren, T.C.; Falaturi, P.; Reiter, R.J. Research into the chronodisruption-cancer theory: The imperative for causal clarification and the danger of causal reductionism. Neuro Endocrinol. Lett. 2010, 31, 1-3.
116. Reiter, R.J.; Tan, D.-X.; Korkmaz, A.; Ma, S. Obesity and metabolic syndrome: Association with chronodisruption, sleep deprivation, and melatonin suppression. Ann. Med. 2012, 44, 564-577.
117. Knutsson, A.; Bøggild, H. Shiftwork and cardiovascular disease: Review of disease mechanisms. Rev. Environ. Health 2000, 15, 359-372.
118. Cho, K.; Ennaceur, A.; Cole, J.C.; Suh, C.K. Chronic jet lag produces cognitive deficits. J. Neurosci. 2000, 20, RC66.
119. Tri Hoang Do, M.; Yau, K. Intrinsically Photosensitive Retinal Ganglion Cells. Physiol. Rev. 2010, 90, 1547-1581.
120. McDougal, D.H.; Gamlin, P.D. The influence of intrinsically-photosensitive retinal ganglion cells on the spectral sensitivity and response dynamics of the human pupillary light reflex. Vision Res. 2010, 50, 72-87.
121. Morgan, W.W.; Kamp, C.W. Dopaminergic amacrine neurons of rat retinas with photoreceptor degeneration continue to respond to light. Life Sci. 1980, 26, 1619-1626.
122. Czeisler, C.A.; Shanahan, T.L.; Klerman, E.B.; Martens, H.; Brotman, D.J.; Emens, J.S.; Klein, T.; Rizzo, J.F. Suppression of melatonin secretion in some blind patients by exposure to bright light. N. Engl. J. Med. 1995, 332, 6-11.
123. Lucas, R.J.; Foster, R.G. Neither functional rod photoreceptors nor rod or cone outer segments are required for the photic inhibition of pineal melatonin. Endocrinology 1999, 140, 1520-1524.
124. Freedman, M.S.; Lucas, R.J.; Soni, B.; von Schantz, M.; Muñoz, M.; David-Gray, Z.; Foster, R. Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. Science 1999, 284, 502-504.
125. Lucas, R.J.; Douglas, R.H.; Foster, R.G. Characterization of an ocular photopigment capable of driving pupillary constriction in mice. Nat. Neurosci. 2001, 4, 621-626.
126. Provencio, I.; Jiang, G.; de Grip, W.J.; Hayes, W.P.; Rollag, M.D. Melanopsin: An opsin in melanophores, brain, and eye. Proc. Natl. Acad. Sci. USA 1998, 95, 340-5.
127. Provencio, I.; Rodriguez, I.R.; Jiang, G.; Hayes, W.P.; Moreira, E.F.; Rollag, M.D. A novel human opsin in the inner retina. J. Neurosci. 2000, 20, 600-605.
128. Hattar, S.; Liao, H.W.; Takao, M.; Berson, D.M.; Yau, K.W. Melanopsin-containing retinal ganglion cells: Architecture, projections, and intrinsic photosensitivity. Science 2002, 295, 1065-1070.
129. Belenky, M.A.; Smeraski, C.A.; Provencio, I.; Sollars, P.J.; Pickard, G.E. Melanopsin retinal ganglion cells receive bipolar and amacrine cell synapses. J. Comp. Neurol. 2003, 460, 380-393.
130. Fain, G.L.; Hardie, R.; Laughlin, S.B. Phototransduction and the evolution of photoreceptors. Curr. Biol. 2010, 20, R114-R124.
131. Yau, K.-W.; Hardie, R.C. Phototransduction motifs and variations. Cell 2009, 139, 246-264.
132. Fahrenkrug, J.; Falktoft, B.; Georg, B.; Rask, L. N-linked deglycosylated melanopsin retains its responsiveness to light. Biochemistry 2009, 48, 5142-5148.
133. Koyanagi, M.; Kubokawa, K.; Tsukamoto, H.; Shichida, Y.; Terakita, A. Cephalochordate melanopsin: Evolutionary linkage between invertebrate visual cells and vertebrate photosensitive retinal ganglion cells. Curr. Biol. 2005, 15, 1065-1069.
134. Mure, L.S.; Cornut, P.-L.; Rieux, C.; Drouyer, E.; Denis, P.; Gronfier, C.; Cooper, H.M. Melanopsin bistability: A fly’s eye technology in the human retina. PLoS One 2009, 4, e5991.
135. Gooley, J.J.; Lu, J.; Fischer, D.; Saper, C.B. A broad role for melanopsin in nonvisual photoreception. J. Neurosci. 2003, 23, 7093-7106.
136. Hannibal, J.; Fahrenkrug, J. Target areas innervated by PACAP-immunoreactive retinal ganglion cells. Cell Tissue Res. 2004, 316, 99-113.
137. Hattar, S.; Kumar, M.; Park, A.; Tong, P.; Tung, J.; Yau, K.-W.; Berson, D.M. Central projections of melanopsin-expressing retinal ganglion cells in the mouse. J. Comp. Neurol. 2006, 497, 326-349.
138. Berson, D.M. Strange vision: Ganglion cells as circadian photoreceptors. Trends Neurosci. 2003, 26, 314-320.
139. Klerman, E.B.; Shanahan, T.L.; Brotman, D.J.; Rimmer, D.W.; Emens, J.S.; Rizzo, J.F.; Czeisler, C.A. Photic resetting of the human circadian pacemaker in the absence of conscious vision. J. Biol. Rhythm. 2002, 17, 548-555.
140. Zaidi, F.H.; Hull, J.T.; Peirson, S.N.; Wulff, K.; Aeschbach, D.; Gooley, J.J.; Brainard, G.C.; Gregory-Evans, K.; Rizzo, J.F.; Czeisler, C.A.; et al. Short-wavelength light sensitivity of circadian, pupillary, and visual awareness in humans lacking an outer retina. Curr. Biol. 2007, 17, 2122-2128.
141. Panda, S.; Sato, T.K.; Castrucci, A.M.; Rollag, M.D.; DeGrip, W.J.; Hogenesch, J.B.; Provencio, I.; Kay, S.A. Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting. Science 2002, 298, 2213-2216.
142. Thompson, S.; Foster, R.G.; Stone, E.M.; Sheffield, V.C.; Mrosovsky, N. Classical and melanopsin photoreception in irradiance detection: Negative masking of locomotor activity by light. Eur. J. Neurosci. 2008, 27, 1973-1979.
143. Tsai, J.W.; Hannibal, J.; Hagiwara, G.; Colas, D.; Ruppert, E.; Ruby, N.F.; Heller, H.C.; Franken, P.; Bourgin, P. Melanopsin as a sleep modulator: Circadian gating of the direct effects of light on sleep and altered sleep homeostasis in Opn4 (-/-) mice. PLoS Biol. 2009, 7, e1000125.
144. Altimus, C.M.; Güler, A.D.; Villa, K.L.; McNeill, D.S.; Legates, T.A.; Hattar, S. Rods-cones and melanopsin detect light and dark to modulate sleep independent of image formation. Proc. Natl. Acad. Sci. USA 2008, 105, 19998-20003.
145. Brown, T.M.; Piggins, H.D. Electrophysiology of the suprachiasmatic circadian clock. Prog. Neurobiol. 2007, 82, 229-255.
146. Panda, S.; Provencio, I.; Tu, D.C.; Pires, S.S.; Rollag, M.D.; Castrucci, A.M.; Pletcher, M.T.; Sato, T.K.; Wiltshire, T.; Andahazy, M.; et al. Melanopsin is required for non-image-forming photic responses in blind mice. Science 2003, 301, 525-527.
147. Lucas, R.J.; Freedman, M.S.; Muñoz, M.; Garcia-Fernández, J.M.; Foster, R.G. Regulation of the mammalian pineal by non-rod, non-cone, ocular photoreceptors. Science 1999, 284, 505-507.
148. Brainard, G.C.; Sliney, D.; Hanifin, J.P.; Glickman, G.; Byrne, B.; Greeson, J.M.; Jasser, S.; Gerner, E.; Rollag, M.D. Sensitivity of the human circadian system to short-wavelength (420-nm) light. J. Biol. Rhythm. 2008, 23, 379-386.
149. Lockley, S.W.; Brainard, G.C.; Czeisler, C.A. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J. Clin. Endocrinol. Metab. 2003, 88, 4502-4505.
150. Thapan, K.; Arendt, J.; Skene, D.J. An action spectrum for melatonin suppression: Evidence for a novel non-rod, non-cone photoreceptor system in humans. J. Physiol. 2001, 535, 261-267.
151. Zhu, Y.; Tu, D.C.; Denner, D.; Shane, T.; Fitzgerald, C.M.; van Gelder, R.N. Melanopsin-dependent persistence and photopotentiation of murine pupillary light responses. Investig. Ophthalmol. Vis. Sci. 2007, 48, 1268-1275.
152. Lucas, R.J.; Hattar, S.; Takao, M.; Berson, D.M.; Foster, R.G.; Yau, K.-W. Diminished papillary light reflex at high irradiances in melanopsin-knockout mice. Science 2003, 299, 245-247.
153. Semo, M.; Peirson, S.; Lupi, D.; Lucas, R.J.; Jeffery, G.; Foster, R.G. Melanopsin retinal ganglion cells and the maintenance of circadian and pupillary responses to light in aged rodless/coneless (rd/rd cl) mice. Eur. J. Neurosci. 2003, 17, 1793-1801.
154. Barnard, A.R.; Appleford, J.M.; Sekaran, S.; Chinthapalli, K.; Jenkins, A.; Seeliger, M.; Biel, M.; Humphries, P.; Douglas, R.H.; Wenzel, A.; et al. Residual photosensitivity in mice lacking both rod opsin and cone photoreceptor cyclic nucleotide gated channel 3 alpha subunit. Vis. Neurosci. 2004, 21, 675-683.
155. Kawasaki, A.; Kardon, R.H. Intrinsically photosensitive retinal ganglion cells. J. Neuroophthalmol. 2007, 27, 195-204.
156. Gooley, J.J.; Mien, I.H.; Hilaire, M.A.S.; Yeo, S.; Chua, E.C.; Reen, E.; van Hanley, C.J.; Hull, J.T.; Czeisler, C.A.; Lockley, S.W. Melanopsin and rod-cone photoreceptors play different roles in mediating pupillary light responses during exposure to continuous light in humans. J. Neurosci. 2012, 32, 14242-14253.
157. Lee, H.S.; Nelms, J.L.; Nguyen, M.; Silver, R.; Lehman, M.N. The eye is necessary for a circadian rhythm in the suprachiasmatic nucleus. Nat. Neurosci. 2003, 6, 111-112.
158. Liu, X.; Zhang, Z.; Ribelayga, C.P. Heterogeneous expression of the core circadian clock proteins among neuronal cell types in mouse retina. PLoS One 2012, 7, e50602.
159. Weng, S.; Wong, K.Y.; Berson, D.M. Circadian modulation of melanopsin-driven light response in rat ganglion-cell photoreceptors. J. Biol. Rhythm. 2009, 24, 391-402.
160. Van Hook, M.J.; Wong, K.Y.; Berson, D.M. Dopaminergic modulation of ganglion-cell photoreceptors in rat. Eur. J. Neurosci. 2012, 35, 507-518.
161. McMahon, D.G.; Iuvone, P.M.; Tosini, G. Circadian organization of the mammalian retina: From gene regulation to physiology and diseases. Prog. Retin. Eye Res. 2014, 39, 58-76.
162. Tosini, G.; Menaker, M. The pineal complex and melatonin affect the expression of the daily rhythm of behavioral thermoregulation in the green iguana. J. Comp. Physiol. A 1996, 179, 135-142.
163. Tosini, G.; Menaker, M. The clock in the mouse retina: Melatonin synthesis and photoreceptor degeneration. Brain Res. 1998, 789, 221-228.
164. Besharse, J.C.; Iuvone, P.M. Circadian clock in Xenopus eye controlling retinal serotonin N-acetyltransferase. Nature 1983, 305, 133-135.
165. Nir, I.; Haque, R.; Iuvone, P.M. Diurnal metabolism of dopamine in the mouse retina. Brain Res. 2000, 870, 118-125.
166. Doyle, S.E.; McIvor, W.E.; Menaker, M. Circadian rhythmicity in dopamine content of mammalian retina: Role of the photoreceptors. J. Neurochem. 2002, 83, 211-219.
167. Doyle, S.E.; Grace, M.S.; McIvor, W.; Menaker, M. Circadian rhythms of dopamine in mouse retina: The role of melatonin. Vis. Neurosci. 2002, 19, 593-601.
168. Jaliffa, C.O.; Saenz, D.; Resnik, E.; Keller Sarmiento, M.I.; Rosenstein, R.E. Circadian activity of the GABAergic system in the golden hamster retina. Brain Res. 2001, 912, 195-202.
169. Barnard, A.R.; Hattar, S.; Hankins, M.W.; Lucas, R.J. Melanopsin regulates visual processing in the mouse retina. Curr. Biol. 2006, 16, 389-395.
170. Storch, K.-F.; Paz, C.; Signorovitch, J.; Raviola, E.; Pawlyk, B.; Li, T.; Weitz, C.J. Intrinsic circadian clock of the mammalian retina: Importance for retinal processing of visual information. Cell 2007, 130, 730-741.
171. Teirstein, P.S.; Goldman, A.I.; O’Brien, P.J. Evidence for both local and central regulation of rat rod outer segment disc shedding. Investig. Ophthalmol. Vis. Sci. 1980, 19, 1268-1273.
172. Von Schantz, M.; Lucas, R.J.; Foster, R.G. Circadian oscillation of photopigment transcript levels in the mouse retina. Brain Res. Mol. Brain Res. 1999, 72, 108-114.
173. Grewal, R.; Organisciak, D.; Wong, P. Factors underlying circadian dependent susceptibility to light induced retinal damage. Adv. Exp. Med. Biol. 2006, 572, 411-416.
174. Organisciak, D.T.; Darrow, R.M.; Barsalou, L.; Kutty, R.K.; Wiggert, B. Circadian-dependent retinal light damage in rats. Investig. Ophthalmol. Vis. Sci. 2000, 41, 3694-3701.
175. Ogilvie, J.M.; Speck, J.D. Dopamine has a critical role in photoreceptor degeneration in the rd mouse. Neurobiol. Dis. 2002, 10, 33-40.
176. Baba, K.; Pozdeyev, N.; Mazzoni, F.; Contreras-Alcantara, S.; Liu, C.; Kasamatsu, M.; Martinez-Merlos, T.; Strettoi, E.; Iuvone, P.M.; Tosini, G. Melatonin modulates visual function and cell viability in the mouse retina via the MT1 melatonin receptor. Proc. Natl. Acad. Sci. USA 2009, 106, 15043-1508.
177. Gekakis, N.; Staknis, D.; Nguyen, H.B.; Davis, F.C.; Wilsbacher, L.D.; King, D.P.; Takahashi, J.S.; Weitz, C.J. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998, 280, 1564-1569.
178. Miyamoto, Y.; Sancar, A. Vitamin B2-based blue-light photoreceptors in the retinohypothalamic tract as the photoactive pigments for setting the circadian clock in mammals. Proc. Natl. Acad. Sci. USA 1998, 95, 6097-6102.
179. Ruan, G.-X.; Zhang, D.-Q.; Zhou, T.; Yamazaki, S.; McMahon, D.G. Circadian organization of the mammalian retina. Proc. Natl. Acad. Sci. USA 2006, 103, 9703-9708.
180. Dorenbos, R.; Contini, M.; Hirasawa, H.; Gustincich, S.; Raviola, E. Expression of circadian clock genes in retinal dopaminergic cells. Vis. Neurosci. 2007, 24, 573-580.
181. Zawilska, J.B.; Iuvone, P.M. Melatonin synthesis in chicken retina: Effect of kainic acid-induced lesions on the diurnal rhythm and D2-dopamine receptor-mediated regulation of serotonin N-acetyltransferase activity. Neurosci. Lett. 1992, 135, 71-74.
182. Thomas, K.B.; Tigges, M.; Iuvone, P.M. Melatonin synthesis and circadian tryptophan hydroxylase activity in chicken retina following destruction of serotonin immunoreactive amacrine and bipolar cells by kainic acid. Brain Res. 1993, 601, 303-307.
183. Liu, C.; Fukuhara, C.; Wessel, J.H.; Iuvone, P.M.; Tosini, G. Localization of Aa-nat mRNA in the rat retina by fluorescence in situ hybridization and laser capture microdissection. Cell Tissue Res. 2004, 315, 197-201.
184. Tosini, G.; Davidson, A.J.; Fukuhara, C.; Kasamatsu, M.; Castanon-Cervantes, O. Localization of a circadian clock in mammalian photoreceptors. FASEB J. 2007, 21, 3866-3871.
185. Tosini, G.; Pozdeyev, N.; Sakamoto, K.; Iuvone, P.M. The circadian clock system in the mammalian retina. Bioessays 2008, 30, 624-633.
186. Iuvone, P.M.; Tosini, G.; Pozdeyev, N.; Haque, R.; Klein, D.C.; Chaurasia, S.S. Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina. Prog. Retin. Eye Res. 2005, 24, 433-456.
187. Sakamoto, K.; Liu, C.; Tosini, G. Classical photoreceptors regulate melanopsin mRNA levels in the rat retina. J. Neurosci. 2004, 24, 9693-9697.
188. Sakamoto, K.; Liu, C.; Kasamatsu, M.; Pozdeyev, N.V; Iuvone, P.M.; Tosini, G. Dopamine regulates melanopsin mRNA expression in intrinsically photosensitive retinal ganglion cells. Eur. J. Neurosci. 2005, 22, 3129-3136.
189. Mathes, A.; Engel, L.; Holthues, H.; Wolloscheck, T.; Spessert, R. Daily profile in melanopsin transcripts depends on seasonal lighting conditions in the rat retina. J. Neuroendocrinol. 2007, 19, 952-957.
190. Zele, A.J.; Feigl, B.; Smith, S.S.; Markwell, E.L. The circadian response of intrinsically photosensitive retinal ganglion cells. PLoS One 2011, 6, e17860.
191. Zhang, D.-Q.; Wong, K.Y.; Sollars, P.J.; Berson, D.M.; Pickard, G.E.; McMahon, D.G. Intraretinal signaling by ganglion cell photoreceptors to dopaminergic amacrine neurons. Proc. Natl. Acad. Sci. USA 2008, 105, 14181-14186.
192. Zhang, D.-Q.; Belenky, M.A.; Sollars, P.J.; Pickard, G.E.; McMahon, D.G. Melanopsin mediates retrograde visual signaling in the retina. PLoS One 2012, 7, e42647.
193. Slominski, A.; Wortsman, J. Neuroendocrinology of the skin. Endocr. Rev. 2000, 21, 457-487.
194. Slominski, A.; Wortsman, J.; Luger, T.; Paus, R.; Solomon, S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 2000, 80, 979-1020.
195. Slominski, A.T.; Zmijewski, M.A.; Skobowiat, C.; Zbytek, B.; Slominski, R.M.; Steketee, J.D. Sensing the environment: Regulation of local and global homeostasis by the skin’s neuroendocrine system. Adv. Anat. Embryol. Cell Biol. 2012, 212, 1-115.
196. Slominski, A.; Zbytek, B.; Szczesniewski, A.; Semak, I.; Kaminski, J.; Sweatman, T.; Wortsman, J. CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am. J. Physiol. Endocrinol. Metab. 2005, 288, E701-E706.
197. Slominski, A.T.; Manna, P.R.; Tuckey, R.C. Cutaneous glucocorticosteroidogenesis: Securing local homeostasis and the skin integrity. Exp. Dermatol. 2014, 23, 369-74.
198. Slominski, A.T.; Zmijewski, M.A.; Zbytek, B.; Tobin, D.J.; Theoharides, T.C.; Rivier, J. Key role of CRF in the skin stress response system. Endocr. Rev. 2013, 34, 827-884.
199. Hardeland, R. Melatonin, hormone of darkness and more: Occurrence, control mechanisms, actions and bioactive metabolites. Cell Mol. Life Sci. 2008, 65, 2001-2018.
200. Dibner, C.; Schibler, U.; Albrecht, U. The mammalian circadian timing system: Organization and coordination of central and peripheral clocks. Annu. Rev. Physiol. 2010, 72, 517-549.
201. Torres-Farfan, C.; Richter, H.G.; Rojas-García, P.; Vergara, M.; Forcelledo, M.L.; Valladares, L.E.; Torrealba, F.; Valenzuela, G.J.; Serón-Ferré, M. mt1 Melatonin receptor in the primate adrenal gland: Inhibition of adrenocorticotropin-stimulated cortisol production by melatonin. J. Clin. Endocrinol. Metab. 2003, 88, 450-458.
202. Torres-Farfan, C.; Richter, H.G.; Germain, A.M.; Valenzuela, G.J.; Campino, C.; Rojas-García, P.; Forcelledo, M.L.; Torrealba, F.; Serón-Ferré, M. Maternal melatonin selectively inhibits cortisol production in the primate fetal adrenal gland. J. Physiol. 2004, 554, 841-856.
203. Torres-Farfan, C.; Serón-Ferré, M.; Dinet, V.; Korf, H.-W. Immunocytochemical demonstration of day/night changes of clock gene protein levels in the murine adrenal gland: Differences between melatonin-proficient (C3H) and melatonin-deficient (C57BL) mice. J. Pineal Res. 2006, 40, 64-70.
204. Saper, C.B.; Scammell, T.E.; Lu, J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005, 437, 1257-1263.
205. Fuller, P.M.; Gooley, J.J.; Saper, C.B. Neurobiology of the sleep-wake cycle: Sleep architecture, circadian regulation, and regulatory feedback. J. Biol. Rhythm. 2006, 21, 482-493.
206. Hardeland, R. New approaches in the management of insomnia: Weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists. Neuropsychiatr. Dis. Treat. 2009, 5, 341-354.
207. Wu, T.; Dong, Y.; Yang, Z.; Kato, H.; Ni, Y.; Fu, Z. Differential resetting process of circadian gene expression in rat pineal glands after the reversal of the light/dark cycle via a 24 h light or dark period transition. Chronobiol. Int. 2009, 26, 793-807.
208. Wongchitrat, P.; Felder-Schmittbuhl, M.-P.; Govitrapong, P.; Phansuwan-Pujito, P.; Simonneaux, V. A noradrenergic sensitive endogenous clock is present in the rat pineal gland. Neuroendocrinology 2011, 94, 75-83.
209. Lewy, A.J.; Wehr, T.A.; Goodwin, F.K.; Newsome, D.A.; Markey, S.P. Light suppresses melatonin secretion in humans. Science 1980, 210, 1267-1269.
210. Bojkowski, C.J.; Aldhous, M.E.; English, J.; Franey, C.; Poulton, A.L.; Skene, D.J.; Arendt, J. Suppression of nocturnal plasma melatonin and 6-sulphatoxymelatonin by bright and dim light in man. Horm. Metab. Res. 1987, 19, 437-440.
211. McIntyre, I.M.; Norman, T.R.; Burrows, G.D.; Armstrong, S.M. Human melatonin suppression by light is intensity dependent. J. Pineal Res. 1989, 6, 149-156.
212. Zeitzer, J.M.; Dijk, D.J.; Kronauer, R.; Brown, E.; Czeisler, C. Sensitivity of the human circadian pacemaker to nocturnal light: Melatonin phase resetting and suppression. J. Physiol. 2000, 526, 695-702.
213. Brainard, G.C.; Hanifin, J.P.; Greeson, J.M.; Byrne, B.; Glickman, G.; Gerner, E.; Rollag, M.D. Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor. J. Neurosci. 2001, 21, 6405-6412.
214. Yasukouchi, A.; Hazama, T.; Kozaki, T. Variations in the light-induced suppression of nocturnal melatonin with special reference to variations in the pupillary light reflex in humans. J. Physiol. Anthropol. 2007, 26, 113-121.
215. Stehle, J.H.; von Gall, C.; Korf, H.-W. Melatonin: A clock-output, a clock-input. J. Neuroendocrinol. 2003, 15, 383-389.
216. Lewy, A.J.; Ahmed, S.; Jackson, J.M.; Sack, R.L. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol. Int. 1992, 9, 380-392.
217. Lewy, A. Clinical implications of the melatonin phase response curve. J. Clin. Endocrinol. Metab. 2010, 95, 3158-3160.
218. Danilenko, K.V.; Verevkin, E.G.; Antyufeev, V.S.; Wirz-Justice, A.; Cajochen, C. The hockey-stick method to estimate evening dim light melatonin onset (DLMO) in humans. Chronobiol. Int. 2014, 31, 349-55.
219. Keijzer, H.; Smits, M.G.; Duffy, J.F.; Curfs, L.M.G. Why the dim light melatonin onset (DLMO) should be measured before treatment of patients with circadian rhythm sleep disorders. Sleep Med. Rev. 2014, 18, 333-339.
220. Sack, R.L.; Lewy, A.J. Melatonin as a chronobiotic: Treatment of circadian desynchrony in night workers and the blind. J. Biol. Rhythm. 1997, 12, 595-603.
221. Lewy, A.J.; Emens, J.; Jackman, A.; Yuhas, K. Circadian uses of melatonin in humans. Chronobiol. Int. 2006, 23, 403-412.
222. Burke, T.M.; Markwald, R.R.; Chinoy, E.D.; Snider, J.A.; Bessman, S.C.; Jung, C.M.; Wright, K.P. Combination of light and melatonin time cues for phase advancing the human circadian clock. Sleep 2013, 36, 1617-1624.
223. Saxvig, I.W.; Wilhelmsen-Langeland, A.; Pallesen, S.; Vedaa, O.; Nordhus, I.H.; Bjorvatn, B. A randomized controlled trial with bright light and melatonin for delayed sleep phase disorder: Effects on subjective and objective sleep. Chronobiol. Int. 2014, 31, 72-86.
224. Hardeland, R.; Cardinali, D.P.; Srinivasan, V.; Spence, D.W.; Brown, G.M.; Pandi-Perumal, S.R. Melatonin-A pleiotropic, orchestrating regulator molecule. Prog. Neurobiol. 2011, 93, 350-384.
225. Messner, M.; Hardeland, R.; Rodenbeck, A.; Huether, G. Tissue retention and subcellular distribution of continuously infused melatonin in rats under near physiological conditions. J. Pineal Res. 1998, 25, 251-259.
226. Venegas, C.; García, J.A.; Escames, G.; Ortiz, F.; López, A.; Doerrier, C.; García-Corzo, L.; López, L.C.; Reiter, R.J.; Acuña-Castroviejo, D. Extrapineal melatonin: Analysis of its subcellular distribution and daily fluctuations. J. Pineal Res. 2012, 52, 217-227.
227. Paradies, G.; Petrosillo, G.; Paradies, V.; Reiter, R.J.; Ruggiero, F.M. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J. Pineal Res. 2010, 48, 297-310.
228. Reiter, R.J.; Tan, D.-X.; Mayo, J.C.; Sainz, R.M.; Leon, J.; Czarnocki, Z. Melatonin as an antioxidant: Biochemical mechanisms and pathophysiological implications in humans. Acta Biochim. Pol. 2003, 50, 1129-1146.
229. Hardeland, R. Antioxidative protection by melatonin: Multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005, 27, 119-130.
230. Galano, A.; Tan, D.X.; Reiter, R.J. Melatonin as a natural ally against oxidative stress: A physicochemical examination. J. Pineal Res. 2011, 51, 1-16.
231. García, J.J.; López-Pingarrón, L.; Almeida-Souza, P.; Tres, A.; Escudero, P.; García-Gil, F.A.; Tan, D.-X.; Reiter, R.J.; Ramírez, J.M.; Bernal-Pérez, M. Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: A review. J. Pineal Res. 2014, 56, 225-237.
232. Korkmaz, A.; Topal, T.; Tan, D.-X.; Reiter, R.J. Role of melatonin in metabolic regulation. Rev. Endocr. Metab. Disord. 2009, 10, 261-270.
233. Ates, O.; Cayli, S.; Gurses, I.; Yucel, N.; Altinoz, E.; Iraz, M.; Kocak, A.; Yologlu, S. Does pinealectomy affect the recovery rate after spinal cord injury? Neurol. Res. 2007, 29, 533-539.
234. Ozler, M.; Simsek, K.; Ozkan, C.; Akgul, E.O.; Topal, T.; Oter, S.; Korkmaz, A. Comparison of the effect of topical and systemic melatonin administration on delayed wound healing in rats that underwent pinealectomy. Scand. J. Clin. Lab. Investig. 2010, 70, 447-452.
235. Tasdemir, S.; Samdanci, E.; Parlakpinar, H.; Polat, A.; Tasdemir, C.; Cengiz, N.; Sapmaz, H.; Acet, A. Effects of pinealectomy and exogenous melatonin on the brains, testes, duodena and stomachs of rats. Eur. Rev. Med. Pharmacol. Sci. 2012, 16, 860-866.
236. Kus, M.A.; Sarsilmaz, M.; Karaca, O.; Acar, T.; Gülcen, B.; Hismiogullari, A.A.; Ogetürk, M.; Kus, I. Effects of melatonin hormone on hippocampus in pinealectomized rats: An immunohistochemical and biochemical study. Neuro Endocrinol. Lett. 2013, 34, 418-425.
237. DeCoursey, P.J. Effect of light on the circadian activity rhythm of the flying squirrel, Glaucomys volans. Zeitschrift für Vergleichende Physiol. 1961, 44, 331-354.
238. Tembrock, G. Winfree, A.T.: The Geometry of Biological Time. (Biomathematics, Vol. 8.). Springer-Verlag, Berlin-Heidelberg-New York 1980, xiv, 530 S., 290 Abb., DM 59.50. Biom. J. 1982, 24, 320.
239. Honma, K.; Honma, S.; Wada, T. Phase-dependent shift of free-running human circadian rhythms in response to a single bright light pulse. Experientia 1987, 43, 1205-1207.
240. Minors, D.S.; Waterhouse, J.M.; Wirz-Justice, A. A human phase-response curve to light. Neurosci. Lett. 1991, 133, 36-40.
241. Van Cauter, E.; Sturis, J.; Byrne, M.M.; Blackman, J.D.; Leproult, R.; Ofek, G.; L’Hermite-Balériaux, M.; Refetoff, S.; Turek, F.W.; van Reeth, O. Demonstration of rapid light-induced advances and delays of the human circadian clock using hormonal phase markers. Am. J. Physiol. 1994, 266, E953-E963.
242. Khalsa, S.B.S.; Jewett, M.E.; Cajochen, C.; Czeisler, C.A. A phase response curve to single bright light pulses in human subjects. J. Physiol. 2003, 549, 945-952.
243. Czeisler, C.A.; Kronauer, R.E.; Allan, J.S.; Duffy, J.F.; Jewett, M.E.; Brown, E.N.; Ronda, J.M. Bright light induction of strong (type 0) resetting of the human circadian pacemaker. Science 1989, 244, 1328-1333.
244. Jewett, M.E.; Kronauer, R.E.; Czeisler, C.A. Phase-amplitude resetting of the human circadian pacemaker via bright light: A further analysis. J. Biol. Rhythm. 1994, 9, 295-314.
245. Rüger, M.; St Hilaire, M.A.; Brainard, G.C.; Khalsa, S.-B.S.; Kronauer, R.E.; Czeisler, C.A.; Lockley, S.W. Human phase response curve to a single 6.5 h pulse of short-wavelength light. J. Physiol. 2013, 591, 353-363.
246. Wang, X.-S.; Armstrong, M.E.G.; Cairns, B.J.; Key, T.J.; Travis, R.C. Shift work and chronic disease: The epidemiological evidence. Occup. Med. (Lond.) 2011, 61, 78-89.
247. Szosland, D. Shift work and metabolic syndrome, diabetes mellitus and ischaemic heart disease. Int. J. Occup. Med. Environ. Health 2010, 23, 287-291.
248. Puttonen, S.; Viitasalo, K.; Härmä, M. The relationship between current and former shift work and the metabolic syndrome. Scand. J. Work. Environ. Health 2012, 38, 343-348.
249. Ye, H.H.; Jeong, J.U.; Jeon, M.J.; Sakong, J. The association between shift work and the metabolic syndrome in female workers. Ann. Occup. Environ. Med. 2013, 25, 33.
250. Kawada, T.; Otsuka, T. Effect of shift work on the development of metabolic syndrome after 3 years in Japanese male workers. Arch. Environ. Occup. Health 2014, 69, 55-61.
251. Wang, F.; Zhang, L.; Zhang, Y.; Zhang, B.; He, Y.; Xie, S.; Li, M.; Miao, X.; Li, Z.; Yu, I.T.-S.; et al. Meta-analysis on night shift work and risk of metabolic syndrome. Occup. Environ. Med. 2014, 71, A78.
252. Kawabe, Y.; Nakamura, Y.; Kikuchi, S.; Murakami, Y.; Tanaka, T.; Takebayashi, T.; Okayama, A.; Miura, K.; Okamura, T.; Ueshima, H. Relationship between shift work and clustering of the metabolic syndrome diagnostic components. J. Atheroscler. Thromb. 2014, 21, 703-711.
253. Pan, A.; Schernhammer, E.S.; Sun, Q.; Hu, F.B. Rotating night shift work and risk of type 2 diabetes: Two prospective cohort studies in women. PLoS Med. 2011, 8, e1001141.
254. Leproult, R.; Holmbäck, U.; van Cauter, E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes 2014, 63, 1860-1869.
255. Mayor, S. Shift work is associated with increased risk of type 2 diabetes, study shows. BMJ 2014, 349, g4804.
256. Gan, Y.; Yang, C.; Tong, X.; Sun, H.; Cong, Y.; Yin, X.; Li, L.; Cao, S.; Dong, X.; Gong, Y.; et al. Shift work and diabetes mellitus: A meta-analysis of observational studies. Occup. Environ. Med. 2014, doi:10.1136/oemed-2014-102150.
257. Lin, Y.-C.; Hsiao, T.-J.; Chen, P.-C. Shift work aggravates metabolic syndrome development among early-middle-aged males with elevated ALT. World J. Gastroenterol. 2009, 15, 5654-5661.
258. Antunes, L.C.; Levandovski, R.; Dantas, G.; Caumo, W.; Hidalgo, M.P. Obesity and shift work: Chronobiological aspects. Nutr. Res. Rev. 2010, 23, 155-168.
259. Lowden, A.; Moreno, C.; Holmbäck, U.; Lennernäs, M.; Tucker, P. Eating and shift work-Effects on habits, metabolism and performance. Scand. J. Work. Environ. Health 2010, 36, 150-162.
260. Chen, J.-D.; Lin, Y.-C.; Hsiao, S.-T. Obesity and high blood pressure of 12-hour night shift female clean-room workers. Chronobiol. Int. 2010, 27, 334-344.
261. Esquirol, Y.; Perret, B.; Ruidavets, J.B.; Marquie, J.C.; Dienne, E.; Niezborala, M.; Ferrieres, J. Shift work and cardiovascular risk factors: New knowledge from the past decade. Arch. Cardiovasc. Dis. 2011, 104, 636-668.
262. Nedeltcheva, A.V.; Scheer, F.A.J.L. Metabolic effects of sleep disruption, links to obesity and diabetes. Curr. Opin. Endocrinol. Diabetes. Obes. 2014, 21, 293-298.
263. Schmid, S.M.; Hallschmid, M.; Schultes, B. The metabolic burden of sleep loss. Lancet. Diabetes Endocrinol. 2014, doi:10.1016/S2213-8587(14)70012-9.
264. Bayon, V.; Leger, D.; Gomez-Merino, D.; Vecchierini, M.-F.; Chennaoui, M. Sleep debt and obesity. Ann. Med. 2014, 46, 264-272.
265. Kant, A.K.; Graubard, B.I. Association of self-reported sleep duration with eating behaviors of American adults: NHANES 2005-2010. Am. J. Clin. Nutr. 2014, 100, 938-947.
266. Burgueño, A.; Gemma, C.; Gianotti, T.F.; Sookoian, S.; Pirola, C.J. Increased levels of resistin in rotating shift workers: A potential mediator of cardiovascular risk associated with circadian misalignment. Atherosclerosis 2010, 210, 625-629.
267. Obayashi, K.; Saeki, K.; Kurumatani, N. Association between light exposure at night and insomnia in the general elderly population: The HEIJO-KYO cohort. Chronobiol. Int. 2014, 31, 976-982.
268. Sivertsen, B.; Pallesen, S.; Glozier, N.; Bjorvatn, B.; Salo, P.; Tell, G.S.; Ursin, R.; Øverland, S. Midlife insomnia and subsequent mortality: The Hordaland health study. BMC Public Health 2014, 14, 720.
269. Hardeland, R.; Coto-Montes, A. New vistas on oxidative damage and aging. Open Biol. J. 2010, 3, 39-52.
270. Aschoff, J.; von Saint Paul, U.; Wever, R. Lifetime of flies under influence of time displacement. Naturwissenschaften 1971, 58, 574.
271. Penev, P.D.; Kolker, D.E.; Zee, P.C.; Turek, F.W. Chronic circadian desynchronization decreases the survival of animals with cardiomyopathic heart disease. Am. J. Physiol. 1998, 275, H2334-H2337.
272. Kasai, H.; Iwamoto-Tanaka, N.; Miyamoto, T.; Kawanami, K.; Kawanami, S.; Kido, R.; Ikeda, M. Life style and urinary 8-hydroxydeoxyguanosine, a marker of oxidative dna damage: Effects of exercise, working conditions, meat intake, body mass index, and smoking. Jpn. J. Cancer Res. 2001, 92, 9-15.
273. Lin, P.-C.; Hung, H.-C.; Pan, S.-M.; Wu, M.-T. The change of oxidative DNA damage in nurses with shift work. Occup. Environ. Med. 2014, 71, A97.
274. Erren, T.C.; Morfeld, P. Shift work and cancer research: A thought experiment into a potential chronobiological fallacy of past and perspectives for future epidemiological studies. Neuro Endocrinol. Lett. 2013, 34, 282-286.
275. Hansen, J. Light at night, shiftwork, and breast cancer risk. J. Natl. Cancer Inst. 2001, 93, 1513-1515.
276. Kolstad, H.A. Nightshift work and risk of breast cancer and other cancers-A critical review of the epidemiologic evidence. Scand. J. Work Environ. Health 2008, 34, 5-22.
277. Hansen, J.; Lassen, C.F. Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup. Environ. Med. 2012, 69, 551-556.
278. Hansen, J.; Stevens, R.G. Case-control study of shift-work and breast cancer risk in Danish nurses: Impact of shift systems. Eur. J. Cancer 2012, 48, 1722-1729.
279. Ijaz, S.; Verbeek, J.; Seidler, A.; Lindbohm, M.-L.; Ojajärvi, A.; Orsini, N.; Costa, G.; Neuvonen, K. Night-shift work and breast cancer-A systematic review and meta-analysis. Scand. J. Work Environ. Health 2013, 39, 431-447.
280. Kamdar, B.B.; Tergas, A.I.; Mateen, F.J.; Bhayani, N.H.; Oh, J. Night-shift work and risk of breast cancer: A systematic review and meta-analysis. Breast Cancer Res. Treat. 2013, 138, 291-301.
281. Fritschi, L.; Erren, T.C.; Glass, D.C.; Girschik, J.; Thomson, A.K.; Saunders, C.; Boyle, T.; El-Zaemey, S.; Rogers, P.; Peters, S.; et al. The association between different night shiftwork factors and breast cancer: A case-control study. Br. J. Cancer 2013, 109, 2472-2480.
282. Tsc, L.A.S.; Wang, F.; Chan, W.C.; Wu, C.; Li, M.; Kwok, C.H.; Leung, S.L.; Yu, W.C.; Yu, I.T.-S. Long-term nightshift work and breast cancer risk in Hong Kong women: Results update. Occup. Environ. Med. 2014, 71, A7-A8.
283. Schernhammer, E. Nighshift work and breast cancer risk-Good news, bad news ? Occup. Environ. Med. 2014, 71, A121.
284. Papantoniou, K.; Kogevinas, M.; Martin Sanchez, V.; Moreno, V.; Pollan, M.; Moleón, J.J.J.; Ardanaz, E.; Maltzibar, J.; Peiro, R.; Tardon, A.; et al. Colorectal cancer risk and shift work in a population-based case-control study in Spain (MCC-Spain). Occup. Environ. Med. 2014, 71, A5-A6.
285. Carter, B.D.; Diver, W.R.; Hildebrand, J.S.; Patel, A.V; Gapstur, S.M. Circadian disruption and fatal ovarian cancer. Am. J. Prev. Med. 2014, 46, S34-S41.
286. Lahti, T.A.; Partonen, T.; Kyyrönen, P.; Kauppinen, T.; Pukkala, E. Night-time work predisposes to non-Hodgkin lymphoma. Int. J. Cancer 2008, 123, 2148-2151.
287. Ursi, M.; Noli, M.; Marras, F.; Aresti, C.; Mannetje, A.; Cocco, P. Risk of non-Hodgkin Lymphoma in health occupations. Occup. Environ. Med. 2014, 71, A113-A114.
288. Carrillo-Vico, A.; Lardone, P.J.; Alvarez-Sánchez, N.; Rodríguez-Rodríguez, A.; Guerrero, J.M. Melatonin: Buffering the immune system. Int. J. Mol. Sci. 2013, 14, 8638-8683.
289. Dauchy, R.T.; Xiang, S.; Mao, L.; Brimer, S.; Wren, M.A.; Yuan, L.; Anbalagan, M.; Hauch, A.; Frasch, T.; Rowan, B.G.; et al. Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer. Cancer Res. 2014, 74, 4099-4110.
290. Vinogradova, I.A.; Anisimov, V.N.; Bukalev, A.V.; Semenchenko, A.V.; Zabezhinski, M.A. Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in rats. Aging 2009, 1, 855-865.
291. Ortiz-Tudela, E.; Martinez-Nicolas, A.; Albares, J.; Segarra, F.; Campos, M.; Estivill, E.; Rol, M.A.; Madrid, J.A. Ambulatory circadian monitoring (ACM) based on thermometry, motor activity and body position (TAP): A comparison with polysomnography. Physiol. Behav. 2014, 126, 30-38.
292. Bonmati-Carrion, M.A.; Middleton, B.; Revell, V.; Skene, D.J.; Rol, M.A.; Madrid, J.A. Circadian phase asessment by ambulatory monitoring in humans : Correlation with dim light Melatonin Onset. 2013, 31, 37-51.
293. Myers, B.L.; Badia, P. Changes in circadian rhythms and sleep quality with aging: Mechanisms and interventions. Neurosci. Biobehav. Rev. 1995, 19, 553-571.
294. Turner, P.L.; Mainster, M.A. Circadian photoreception: Ageing and the eye’s important role in systemic health. Br. J. Ophthalmol. 2008, 92, 1439-1444.
295. Najjar, R.P.; Chiquet, C.; Teikari, P.; Cornut, P.-L.; Claustrat, B.; Denis, P.; Cooper, H.M.; Gronfier, C. Aging of non-visual spectral sensitivity to light in humans: Compensatory mechanisms? PLoS One 2014, 9, e85837.
296. Yang, Y.; Thompson, K.; Burns, S.A. Pupil location under mesopic, photopic and pharmacologically dilated conditions. Investig. Ophthalmol. Vis. Sci. 2002, 43, 2508-2512.
297. Charman, W.N. Age, lens transmittance, and the possible effects of light on melatonin suppression. Ophthalmic Physiol. Opt. 2003, 23, 181-187.
298. Revell, V.L.; Skene, D.J. Impact of age on human non-visual responses to light. Sleep Biol. Rhythm. 2010, 8, 84-94.
299. Herbst, K.; Sander, B.; Lund-Andersen, H.; Broendsted, A.E.; Kessel, L.; Hansen, M.S.; Kawasaki, A. Intrinsically photosensitive retinal ganglion cell function in relation to age: A pupillometric study in humans with special reference to the age-related optic properties of the lens. BMC Ophthalmol. 2012, 12, 4.
300. Harman, A.; Abrahams, B.; Moore, S.; Hoskins, R. Neuronal density in the human retinal ganglion cell layer from 16 to 77 years. Anat. Rec. 2000, 260, 124-131.
301. Curcio, C.A.; Owsley, C.; Jackson, G.R. Spare the rods, save the cones in aging and age-related maculopathy. Investig. Ophthalmol. Vis. Sci. 2000, 41, 2015-2018.
302. Li, R.S.; Chen, B.-Y.; Tay, D.K.; Chan, H.H.L.; Pu, M.-L.; So, K.-F. Melanopsin-expressing retinal ganglion cells are more injury-resistant in a chronic ocular hypertension model. Investig. Ophthalmol. Vis. Sci. 2006, 47, 2951-2958.
303. Roberts, D.E.; Killiany, R.J.; Rosene, D.L. Neuron numbers in the hypothalamus of the normal aging rhesus monkey: Stability across the adult lifespan and between the sexes. J. Comp. Neurol. 2012, 520, 1181-1197.
304. Bottum, K.; Poon, E.; Haley, B.; Karmarkar, S.; Tischkau, S.A. Suprachiasmatic nucleus neurons display endogenous resistance to excitotoxicity. Exp. Biol. Med. (Maywood) 2010, 235, 237-246.
305. Gibson, E.M.; Williams, W.P.; Kriegsfeld, L.J. Aging in the circadian system: Considerations for health, disease prevention and longevity. Exp. Gerontol. 2009, 44, 51-56.
306. Weinert, H.; Weinert, D.; Schurov, I.; Maywood, E.S.; Hastings, M.H. Impaired expression of the mPer2 circadian clock gene in the suprachiasmatic nuclei of aging mice. Chronobiol. Int. 2001, 18, 559-565.
307. Asai, M.; Yoshinobu, Y.; Kaneko, S.; Mori, A.; Nikaido, T.; Moriya, T.; Akiyama, M.; Shibata, S. Circadian profile of Per gene mRNA expression in the suprachiasmatic nucleus, paraventricular nucleus, and pineal body of aged rats. J. Neurosci. Res. 2001, 66, 1133-1139.
308. Kolker, D.E.; Fukuyama, H.; Huang, D.S.; Takahashi, J.S.; Horton, T.H.; Turek, F.W. Aging alters circadian and light-induced expression of clock genes in golden hamsters. J. Biol. Rhythm. 2003, 18, 159-169.
309. Kunieda, T.; Minamino, T.; Katsuno, T.; Tateno, K.; Nishi, J.; Miyauchi, H.; Orimo, M.; Okada, S.; Komuro, I. Cellular senescence impairs circadian expression of clock genes in vitro and in vivo. Circ. Res. 2006, 98, 532-539.
310. Kondratov, R.V; Antoch, M.P. The clock proteins, aging, and tumorigenesis. Cold Spring Harb. Symp. Quant. Biol. 2007, 72, 477-482.
311. Dijk, D.J.; Duffy, J.F.; Riel, E.; Shanahan, T.L.; Czeisler, C.A. Ageing and the circadian and homeostatic regulation of human sleep during forced desynchrony of rest, melatonin and temperature rhythms. J. Physiol. 1999, 516, 611-627.
312. Kunz, D.; Schmitz, S.; Mahlberg, R.; Mohr, A.; Stöter, C.; Wolf, K.J.; Herrmann, W.M. A new concept for melatonin deficit: On pineal calcification and melatonin excretion. Neuropsychopharmacology 1999, 21, 765-72.
313. Schmid, H.A.; Requintina, P.J.; Oxenkrug, G.F.; Sturner, W. Calcium, calcification, and melatonin biosynthesis in the human pineal gland: A postmortem study into age-related factors. J. Pineal Res. 1994, 16, 178-183.
314. Zeitzer, J.M.; Daniels, J.E.; Duffy, J.F.; Klerman, E.B.; Shanahan, T.L.; Dijk, D.J.; Czeisler, C.A. Do plasma melatonin concentrations decline with age? Am. J. Med. 1999, 107, 432-436.
315. Van Dijk, K.R.A.; Luijpen, M.W.; van Someren, E.J.W.; Sergeant, J.A.; Scheltens, P.; Scherder, E.J.A. Peripheral electrical nerve stimulation and rest-activity rhythm in Alzheimer’s disease. J. Sleep Res. 2006, 15, 415-423.
316. Mishima, K.; Tozawa, T.; Satoh, K.; Matsumoto, Y.; Hishikawa, Y.; Okawa, M. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep-waking. Biol. Psychiatry 1999, 45, 417-421.
317. Sharma, G. Introduction to Color Imaging Science [Book Review]. IEEE Signal Process. Mag. 2006, 23, 690.
318. Campbell, S.S.; Kripke, D.F.; Gillin, J.C.; Hrubovcak, J.C. Exposure to light in healthy elderly subjects and Alzheimer’s patients. Physiol. Behav. 1988, 42, 141-44.
319. Ancoli-Israel, S.; Klauber, M.R.; Jones, D.W.; Kripke, D.F.; Martin, J.; Mason, W.; Pat-Horenczyk, R.; Fell, R. Variations in circadian rhythms of activity, sleep, and light exposure related to dementia in nursing-home patients. Sleep 1997, 20, 18-23.
320. Anderiesen, H.; Scherder, E.J.A.; Goossens, R.H.M.; Sonneveld, M.H. A systematic review-Physical activity in dementia: The influence of the nursing home environment. Appl. Ergon. 2014, 45, 1678-1686.
321. Lockley, S.W.; Arendt, J.; Skene, D.J. Visual impairment and circadian rhythm disorders. 2007, 9, 301-314.
322. Hollwich, F.; Dieckhues, B. Circadian rhythm in the blind. J. Interdisiplinary Cycle Res. 1971, 2, 291-301.
323. Orth, D.N.; Island, D.P. Light synchronization of the circadian rhythm in plasma cortisol (17-OHCS) concentration in man. J. Clin. Endocrinol. Metab. 1969, 29, 479-486.
324. Krieger, D.T.; Rizzo, F. Circadian periodicity of plasma 11-hydroxycorticosteroid levels in subjects with partial and absent light perception. Neuroendocrinology 1971, 8, 165-169.
325. Bodenheimer, S.; Winter, J.S.; Faiman, C. Diurnal rhythms of serum gonadotropins, testosterone, estradiol and cortisol in blind men. J. Clin. Endocrinol. Metab. 1973, 37, 472-475.
326. D’Alessandro, B.; Bellastella, A.; Esposito, V.; Colucci, C.F.; Montalbetti, N. Letter: Circadian rhythm of cortisol secretion in elderly and blind subjects. Br. Med. J. 1974, 2, 274.
327. Migeon, C.J.; Tyler, F.H.; Mahoney, J.P.; Florentin, A.A.; Castle, H.; Bliss, E.L.; Samuels, L.T. The diurnal variation of plasma levels and urinary excretion on 17-hydroxycorticosteroids in normal subjects, night workers and blind subjects. J. Clin. Endocrinol. Metab. 1956, 16, 622-633.
328. Weitzman, E.; Perlow, M.; Sassin, J.; Fukushima, D.; Burack, B.; Hellman, L. Persistence of the twenty-four hour pattern of episodic cortisol secretion and growth hormone release in blind subjects. Trans. Am. Neurol. Assoc. 1972, 97, 197-199.
329. Scheving, L.E.; Kanabrocki, E.L.; Tsai, T.H.; Pauly, J.E. Circadian and other variation in epinephrine and norepinephrine among several human populations, including healthy blinded and sighted subjects and patients with leprosy. Prog. Clin. Biol. Res. 1987, 227A, 329-349.
330. Lewy, A.J.; Newsome, D.A. Different types of melatonin circadian secretory rhythms in some blind subjects. J. Clin. Endocrinol. Metab. 1983, 56, 1103-1107.
331. Sack, R.L.; Lewy, A.J.; Blood, M.L.; Keith, L.D.; Nakagawa, H. Circadian rhythm abnormalities in totally blind people: Incidence and clinical significance. J. Clin. Endocrinol. Metab. 1992, 75, 127-134.
332. Tabandeh, H.; Lockley, S.W.; Buttery, R.; Skene, D.J.; Defrance, R.; Arendt, J.; Bird, A.C. Disturbance of sleep in blindness. Am. J. Ophthalmol. 1998, 126, 707-712.
333. Skene, D.J.; Lockley, S.W.; James, K.; Arendt, J. Correlation between urinary cortisol and 6-sulphatoxymelatonin rhythms in field studies of blind subjects. Clin. Endocrinol. (Oxf.) 1999, 50, 715-719.
334. Miles, L.; Wilson, M.A. High incidence of cyclic sleep/wake disorders in the blind. Sleep Res. 1977, 6, 192.
335. Miles, L.E.; Raynal, D.M.; Wilson, M.A. Blind man living in normal society has circadian rhythms of 24.9 h. Science 1977, 198, 421-423.
336. Martens, H.; Endlich, H.; Hildebrandt, G.; Moog, R. Sleep/wake distribution in blind subjects with and without sleep complaints. Sleep Res. 1990, 19, 398.
337. Lockley, S.W.; Skene, D.J.; Arendt, J.; Tabandeh, H.; Bird, A.C.; Defrance, R. Relationship between melatonin rhythms and visual loss in the blind. J. Clin. Endocrinol. Metab. 1997, 82, 3763-3770.
338. Skene, D.; Lockley, S.W.; Arendt, J. Melatonin in circadian sleep disorders in the blind. Biol. Signals Recept. 1999, 8, 90-95.
339. Lockley, S.W.; Skene, D.J.; James, K.; Thapan, K.; Wright, J.; Arendt, J. Melatonin administration can entrain the free-running circadian system of blind subjects. J. Endocrinol. 2000, 164, R1-R6.
340. Hack, L.M.; Lockley, S.W.; Arendt, J.; Skene, D.J. The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects. J. Biol. Rhythm. 2003, 18, 420-429.
341. Skene, D.J.; Arendt, J. Circadian rhythm sleep disorders in the blind and their treatment with melatonin. Sleep Med. 2007, 8, 651-655.
342. Gronfier, C.; Wright, K.P.; Kronauer, R.E.; Czeisler, C.A. Entrainment of the human circadian pacemaker to longer-than-24-h days. Proc. Natl. Acad. Sci. USA 2007, 104, 9081-9086.
343. Aries, M. Human Lighting Demands; Eindhoven University Press: Eindhoven, The Netherlands, 2005.
344. Van Bommel, W.J.M. Non-visual biological effect of lighting and the practical meaning for lighting for work. Appl. Ergon. 2006, 37, 461-466.
345. Rea, M.; Figueiro, M.; Bullough, J. Circadian photobiology: An emerging framework for lighting practice and research. Light. Res. Technol. 2002, 34, 177-190.
346. Van Bommel, W.; van den Beld, G. Lighting for work: A review of visual and biological effects. Light. Res. Technol. 2004, 36, 255-269.
347. Rea, M.; Figueiro, M.; Bierman, A.; Hamner, R. Modelling the spectral sensitivity of the human circadian system. Light. Res. Technol. 2011, 44, 386-396.
348. Godley, B.F.; Shamsi, F.A.; Liang, F.-Q.; Jarrett, S.G.; Davies, S.; Boulton, M. Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J. Biol. Chem. 2005, 280, 21061-21066.
349. Nakanishi-Ueda, T.; Majima, H.J.; Watanabe, K.; Ueda, T.; Indo, H.P.; Suenaga, S.; Hisamitsu, T.; Ozawa, T.; Yasuhara, H.; Koide, R. Blue LED light exposure develops intracellular reactive oxygen species, lipid peroxidation, and subsequent cellular injuries in cultured bovine retinal pigment epithelial cells. Free Radic. Res. 2013, 47, 774-780.
350. Chamorro, E.; Bonnin-Arias, C.; Pérez-Carrasco, M.J.; Muñoz de Luna, J.; Vázquez, D.; Sánchez-Ramos, C. Effects of light-emitting diode radiations on human retinal pigment epithelial cells in vitro. Photochem. Photobiol. 2013, 89, 468-473.
351. Shang, Y.-M.; Wang, G.-S.; Sliney, D.; Yang, C.-H.; Lee, L.-L. White light-emitting diodes (LEDs) at domestic lighting levels and retinal injury in a rat model. Environ. Health Perspect. 2014, 122, 269-276.
352. Rahman, S.A.; Marcu, S.; Shapiro, C.M.; Brown, T.J.; Casper, R.F. Spectral modulation attenuates molecular, endocrine, and neurobehavioral disruption induced by nocturnal light exposure. Am. J. Physiol. Endocrinol. Metab. 2011, 300, E518-E527.
353. Rahman, S.A; Shapiro, C.M.; Wang, F.; Ainlay, H.; Kazmi, S.; Brown, T.J.; Casper, R.F. Effects of filtering visual short wavelengths during nocturnal shiftwork on sleep and performance. Chronobiol. Int. 2013, 30, 951-962.
354. Sasseville, A.; Hébert, M. Using blue-green light at night and blue-blockers during the day to improves adaptation to night work: A pilot study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34, 1236-1242.
355. Campbell, S.S.; Terman, M.; Lewy, A.J.; Dijk, D.J.; Eastman, C.I.; Boulos, Z. Light treatment for sleep disorders: Consensus report. V. Age-related disturbances. J. Biol. Rhythm. 1995, 10, 151-154.
356. Fontana Gasio, P.; Kräuchi, K.; Cajochen, C.; Someren, E.; van Amrhein, I.; Pache, M.; Savaskan, E.; Wirz-Justice, A. Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly. Exp. Gerontol. 2003, 38, 207-216.
357. Rodin, I. Seasonal Affective Disorder: Practice and Research; Partonen, T., Magnusson, A., Eds.; Oxford University: Oxford, UK, 2001; Volume 20, p. 311.
358. Gaston, K.J.; Bennie, J.; Davies, T.W.; Hopkins, J. The ecological impacts of nighttime light pollution: A mechanistic appraisal. Biol. Rev. Camb. Philos. Soc. 2013, 88, 912-927.
359. Aschoff, J. The phase-angle difference in circadian periodicity. In Circadian Clocks; North-Holland Publishing Co.; Amsterdam, The Netherlands, 1965; pp. 262-276.
360. Wever, R. A mathematical model for circadian rhythms. In Circadian Clocks; Aschoff, J., Ed.; North-Holland Publishing Co.: Amsterdam, The Netherlands, 1965; pp. 47-73.
361. Terman, M.; Schlager, D.; Fairhurst, S.; Perlman, B. Dawn and dusk simulation as a therapeutic intervention. Biol. Psychiatry 1989, 25, 966-970.
362. Terman, M.; Terman, J.S. Light therapy. In Principles and Practise of Sleep Medicine; Kryger, M.H., Roth, T., Dement, W.C., Eds.; Elsevier: Philadelphia, PA, USA, 2005; pp. 1424-1442.
363. Ohashi, Y.; Okamoto, N.; Uchida, K.; Iyo, M.; Mori, N.; Morita, Y. Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer’s type. Biol. Psychiatry 1999, 45, 1646-1652.
364. Hardeland, R. Melatonin in aging and disease-multiple consequences of reduced secretion, options and limits of treatment. Aging Dis. 2012, 3, 194-225.
365. Mishima, K.; Hishikawa, Y.; Okawa, M. Randomized, dim light controlled, crossover test of morning bright light therapy for rest-activity rhythm disorders in patients with vascular dementia and dementia of Alzheimer’s type. Chronobiol. Int. 1998, 15, 647-54.
366. Ancoli-Israel, S.; Gehrman, P.; Martin, J.L.; Shochat, T.; Marler, M.; Corey-Bloom, J.; Levi, L. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer’s disease patients. Behav. Sleep Med. 2003, 1, 22-36.
367. Dowling, G.A.; Hubbard, E.M.; Mastick, J.; Luxenberg, J.S.; Burr, R.L.; van Someren, E.J.W. Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer’s disease. Int. Psychogeriatr. 2005, 17, 221-236.
368. Dowling, G.A.; Burr, R.L.; van Someren, E.J.W.; Hubbard, E.M.; Luxenberg, J.S.; Mastick, J.; Cooper, B.A. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer’s disease. J. Am. Geriatr. Soc. 2008, 56, 239-246.
369. Dowling, G.A.; Graf, C.L.; Hubbard, E.M.; Luxenberg, J.S. Light treatment for neuropsychiatric behaviors in Alzheimer’s disease. West. J. Nurs. Res. 2007, 29, 961-975.
370. Yamadera, H.; Ito, T.; Suzuki, H.; Asayama, K.; Ito, R.; Endo, S. Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry Clin. Neurosci. 2000, 54, 352-353.
371. Wu, Y.-H.; Swaab, D.F. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer’s disease. Sleep Med. 2007, 8, 623-636.
372. Asayama, K.; Yamadera, H.; Ito, T.; Suzuki, H.; Kudo, Y.; Endo, S. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J. Nippon Med. Sch. 2003, 70, 334-341.
373. Hardeland, R. Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction. Sci. World J. 2012, 2012, 640389.
374. Aoki, M.; Yokota, Y.; Hayashi, T.; Kuze, B.; Murai, M.; Mizuta, K.; Ito, Y. Disorder of the saliva melatonin circadian rhythm in patients with Meniere’s disease. Acta Neurol. Scand. 2006, 113, 256-261.
375. Rohr, U.D.; Herold, J. Melatonin deficiencies in women. Maturitas 2002, 41, S85-S104.
376. Claustrat, B.; Loisy, C.; Brun, J.; Beorchia, S.; Arnaud, J.L.; Chazot, G. Nocturnal plasma melatonin levels in migraine: A preliminary report. Headache 1989, 29, 242-245.
377. Claustrat, B.; Brun, J.; Geoffriau, M.; Zaidan, R.; Mallo, C.; Chazot, G. Nocturnal plasma melatonin profile and melatonin kinetics during infusion in status migrainosus. Cephalalgia 1997, 17, 511-517.
378. Brugger, P.; Marktl, W.; Herold, M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995, 345, 1408.
379. Girotti, L.; Lago, M.; Ianovsky, O.; Carbajales, J.; Elizari, M.V; Brusco, L.I.; Cardinali, D.P. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease. J. Pineal Res. 2000, 29, 138-142.
380. Sewerynek, E. Melatonin and the cardiovascular system. Neuro Endocrinol. Lett. 2002, 23, 79-83.
381. Altun, A.; Yaprak, M.; Aktoz, M.; Vardar, A.; Betul, U.A.; Ozbay, G. Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X. Neurosci. Lett. 2002, 327, 143-145.
382. Yaprak, M.; Altun, A.; Vardar, A.; Aktoz, M.; Ciftci, S.; Ozbay, G. Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. Int. J. Cardiol. 2003, 89, 103-107.
383. Dominguez-Rodriguez, A.; Abreu-Gonzalez, P.; Garcia-Gonzalez, M.J.; Samimi-Fard, S.; Kaski, J.C.; Reiter, R.J. Light/dark patterns of soluble vascular cell adhesion molecule-1 in relation to melatonin in patients with ST-segment elevation myocardial infarction. J. Pineal Res. 2008, 44, 65-69.
384. Dominguez-Rodriguez, A.; Abreu-Gonzalez, P.; Reiter, R.J. Clinical aspects of melatonin in the acute coronary syndrome. Curr. Vasc. Pharmacol. 2009, 7, 367-373.
385. Perras, B.; Kurowski, V.; Dodt, C. Nocturnal melatonin concentration is correlated with illness severity in patients with septic disease. Intensiv. Care Med. 2006, 32, 624-625.
386. Srinivasan, V.; Pandi-Perumal, S.R.; Spence, D.W.; Kato, H.; Cardinali, D.P. Melatonin in septic shock: Some recent concepts. J. Crit. Care 2010, 25, 656 e1-e6.
387. Grin, W.; Grünberger, W. A significant correlation between melatonin deficiency and endometrial cancer. Gynecol. Obstet. Investig. 1998, 45, 62-65.
388. Hu, S.; Shen, G.; Yin, S.; Xu, W.; Hu, B. Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer. Adv. Ther. 2009, 26, 886-892.
389. Puy, H.; Deybach, J.C.; Baudry, P.; Callebert, J.; Touitou, Y.; Nordmann, Y. Decreased nocturnal plasma melatonin levels in patients with recurrent acute intermittent porphyria attacks. Life Sci. 1993, 53, 621-627.
390. Bylesjö, I.; Forsgren, L.; Wetterberg, L. Melatonin and epileptic seizures in patients with acute intermittent porphyria. Epileptic Disord. 2000, 2, 203-208.
391. O’Brien, I.A.; Lewin, I.G.; O’Hare, J.P.; Arendt, J.; Corrall, R.J. Abnormal circadian rhythm of melatonin in diabetic autonomic neuropathy. Clin. Endocrinol. (Oxf.) 1986, 24, 359-364.
392. Peschke, E.; Stumpf, I.; Bazwinsky, I.; Litvak, L.; Dralle, H.; Mühlbauer, E. Melatonin and type 2 diabetes-A possible link? J. Pineal Res. 2007, 42, 350-358.
393. Clark, I.A.; Vissel, B. Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease. Biochem. Pharmacol. 2013, 86, 862-871.
394. Jiang, T.; Yu, J.-T.; Zhu, X.-C.; Tan, L. TREM2 in Alzheimer’s disease. Mol. Neurobiol. 2013, 48, 180-185.
395. De Felice, F.G.; Lourenco, M.V.; Ferreira, S.T. How does brain insulin resistance develop in Alzheimer’s disease? Alzheimers Dement. 2014, 10, S26-S32.
396. De la Monte, S.M.; Tong, M. Brain metabolic dysfunction at the core of Alzheimer’s disease. Biochem. Pharmacol. 2014, 88, 548-559.
397. Ferreira, S.T.; Clarke, J.; Bomfim, T.; de Felice, F.G. Inflammation, defective insulin signaling, and neurological dysfunction in Alzheimer’s disease. Alzheimers Dement. 2014, 10, S76-S83.
398. Lockley, S.W.; Evans, E.E.; Scheer, F.A.J.L.; Brainard, G.C.; Czeisler, C.A.; Aeschbach, D. Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep 2006, 29, 161-168.